Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06305949
Other study ID # XC23DDDS0098
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date December 31, 2025

Study information

Verified date March 2024
Source NEUROPHET
Contact TaeYeong Kim
Phone 827051678882
Email ty.kim@neurophet.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to evaluate whether the application of optimized transcranial direct current stimulation is more effective compared to sham stimulation for temporary improvement of swallowing function in patients with post-stroke dysphagia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 31, 2025
Est. primary completion date July 31, 2025
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - men and women >19 years old - patients with stroke confirmed by neuroimaging - first-time stroke patients - patients in subacute or chronic phases of stroke with 3 weeks or more after onset - stroke patients with confirmed dysphagia through Videofluoroscopic Swallowing Study (VFSS). Exclusion Criteria: - patients with recurrent stoke, traumatic brain injury, spine cord injury, and degenerative brain disease, such as Parkinson's disease, etc. - patients with deteriorated cognitive function unable to perform the clinical trial as instructed - patients with evidence of delirium, confusion, or other impairment of consciousness - patients with uncontrolled medical disease or surgical conditions - patients ineligible for Transcranial direct current stimulation (due to scalp condition, metallic material at the electrode attachment area, presence of a pacemaker or cochlear implant) - patients with previous experience within the last year using a stimulation device similar to the one use in this clinical trial or who have participated in related clinical trials - patients with severe neurologic disorder with concomitant major psychiatric disorder such as major depressive disorder and dementia - patients with history of uncontrolled epilepsy within 6 months - patients with medical contraindications for neuroimaging test, such as MRI; - patients who are taken contraindicated medications or require medication changes during the trial period that could influence cognitive/motor function changes via brain activation changes - patients who are pregnant, breastfeeding, or planning pregnancy during the trial period - patients considered medically ineligible for participation in the present trial beyond the criteria listened above.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Personalized transcranial Direct Current Stimulation
transcranial Direct Current Stimulation 2mA for 30 min; The anode electrode will be located over the ipsilesional representation of the motor cortex swallowing area, while the cathode electrode will be positioned on the contralesional side

Locations

Country Name City State
n/a

Sponsors (5)

Lead Sponsor Collaborator
NEUROPHET Bucheon St. Mary's Hospital, National Traffic Injury Rehabilitation Hospital, Pusan National University Yangsan Hospital, Saint Vincent's Hospital, Korea

Outcome

Type Measure Description Time frame Safety issue
Primary Functional Oral Intake Scale (FOIS) FOIS is a scale used for purposes to assess changes in functional oral intake of food and liquids in patients with dysphagia. FOIS is sensitive to changes in oral intake of food and liquid over time in stroke patients. The scale ranges from level 1 (nothing by mouth) to level 7 (a full unrestricted oral diet) Baseline, At 4 weeks from baseline
Primary Penetration-aspiration Scale (PAS) PAS is a standard scale to assess deglutition in clinical practice and research. It is composed of an 8-point scale used to characterize both the location of airway invasion events and patient's response during video fluoroscopic swallowing studies. The scale design to capture three constructs: depth of airway invasion, material remaining after swallow, and patient's response to aspiration. The scale ranges from score 1 (Material does not enter the airway) to score 8 (Material enters the airway, passes below the level of the vocal folds, and no effort is made to eject) Baseline, At 4 weeks from baseline
Secondary Functional Oral Intake Scale (FOIS) FOIS is a scale used for purposes to assess changes in functional oral intake of food and liquids in patients with dysphagia. FOIS is sensitive to changes in oral intake of food and liquid over time in stroke patients. The scale ranges from level 1 (nothing by mouth) to level 7 (a full unrestricted oral diet) Baseline, At 2, 4, and 8 weeks from baseline
Secondary Penetration-aspiration Scale (PAS) PAS is a standard scale to assess deglutition in clinical practice and research. It is composed of an 8-point scale used to characterize both the location of airway invasion events and patient's response during video fluoroscopic swallowing studies. The scale design to capture three constructs: depth of airway invasion, material remaining after swallow, and patient's response to aspiration. The scale ranges from score 1 (Material does not enter the airway) to score 8 (Material enters the airway, passes below the level of the vocal folds, and no effort is made to eject) Baseline, At 2, 4, and 8 weeks from baseline
Secondary Videofluoroscopic Dysphagia Scale (VDS) The scale contains 14 categories that represent both oral functions (lip, closure, mastication , bolus formation, premature bolus loss, apraxia and oral transit time) and pharyngeal functions (pharyngeal triggering, laryngeal elevation, epiglottic closure, pharyngeal transit time, pharyngeal coating, vallecular and pyriform sinus residues, and tracheal aspiration), with a sum of 100 points. Baseline, At 2, 4, and 8 weeks from baseline
Secondary Korean Mann Assessment of Swallowing Ability (K-MASA) K-MASA assesses 24 skills related to sensory and oral motor elements of swallowing. Performance for each skill is measured using a 5- or 10-points rating scale and tallied to create a total numeric score out of 200 possible points, which are interpreted as no abnormality (=178), mild dysphagia (168-177), moderate dysphagia (139-167) and severe (=138) Baseline, At 2, 4, and 8 weeks from baseline
Secondary Speech Mechanism Screening Test (SMST) The test consists of 13 questions to evaluate the structure of the articulatory system, including the face, lips, tongue, jaw, teeth, oral cavity, soft palate, pharynx, and breathing; 17 questions to evaluate the function of the articulatory system; 3 questions to auditorily evaluate the structure and function of the vocal system; and 14 questions to evaluate the regularity and articulation accuracy of the mutual movement of the articulatory system during articulatory alternation. Baseline, At 4, and 8 weeks from baseline
Secondary Urimal Test of Articulation and Phonology (U-TAP) U-TAP is a test designed for native speakers of the Korean language. It is aimed to evaluate the pronunciation produced in words and sentences by patients with speech sound disorders who have problems with consonant or vowel sounds. It is recorded by phonological word and syllable position and calculates consonant accuracy and word-level phonological indices at the word and sentence levels to compare with normal articulation development Baseline, At 4, and 8 weeks from baseline
Secondary modified Rankin Scale (mRS) mRS is composed of a 6-point assessment that includes reference to both limitations in activity and changes in lifestyle. The mRS possible scores vary from 0 (no symptoms) to 6 (dead) points Baseline, At 2, 4, and 8 weeks from baseline
Secondary Gugging Swallowing Screen The assessment is composed of two parts, the preliminary assessment (indirect swallowing test) and the direct swallowing test, which consist of 4 items with 3 subtests (semisolid, liquid and solid). The test is based on a pointing system where higher numbers denote better performance, with a maximum of 5 points that can be reached in each subtest. Baseline, At 2, 4, and 8 weeks from baseline
Secondary Eating Assessment Tool-10 (EAT-10) The EAT-10 is a tool to assess self-perceived symptoms of oropharyngeal dysphagia and monitor changes in response to a treatment. It consists of ten items to be rated on a 5-point response scale (0-4), with "0" = No problem and "4" = Severe problem, the maximum score possible is 40. Baseline, At 2, 4, and 8 weeks from baseline
Secondary Iowa Oral Performance Instrument (IOPI) IOPI is a standardized portable device that is used to quantify tongue and lips isometric strength and endurance. Baseline, At 4, and 8 weeks from baseline
Secondary Motor-Evoked Potential (MEP) The cortical excitability of the area corresponding to the swallowing movement will be assessed by changes in the amplitude and latency of the MEPs by using transcranial magnetic stimulation (TMS). Baseline, At 2 and 4 weeks from baseline
Secondary Grade, Roughness, Breathiness, Asthenia and Strain scale(GRBAS scale) GRBAS scale is used by researchers and clinicians for rating voice quality using a 4-point Likert scale with the following judgments: 0 = normal, 1 = mild impairment, 2 = moderate impairment, and 3 = severe impairment. Baseline, At 4, and 8 weeks from baseline
Secondary Respiratory muscle strength Respiratory muscle strength will be assessed by maximal inspiratory and expiratory pressure Baseline, At 4, and 8 weeks from baseline
Secondary Peak cough flow Peak cough flow measures the maximum expiratory flow during the compressive phase of a cough just after sudden opening of the glottis Baseline, At 4, and 8 weeks from baseline
See also
  Status Clinical Trial Phase
Completed NCT00570557 - Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia N/A
Completed NCT04243577 - Wearable Monitoring Systems for Swallowing Function and Disorders Early Phase 1
Recruiting NCT03975465 - EMST and Swallowing in Long-Term Survivors of HNCA N/A
Completed NCT05013918 - Oral Health and Nutrition Integrated Care Model
Recruiting NCT05439447 - A Study on Building a Voice Cohort for the Development of a Non-face-to-face Machine Learning Diagnostic and Monitoring Platform Using Voice Analysis and Various Sensors in Patients With Dysphagia.
Recruiting NCT05149976 - Establishment of Voice Analysis Cohort for Development of Monitoring Technology for Dysphagia
Recruiting NCT05978700 - Effectiveness of Video-game Based Swallowing Function Training in Patients With Dysphagia N/A
Recruiting NCT06219200 - Automatic Voice Analysis for Dysphagia Screening in Neurological Patients
Enrolling by invitation NCT02935946 - Cold Liquids Fed to Preterm Infants: Efficacy and Safety After 10 Minutes of Exposure N/A
Withdrawn NCT02925507 - Computerized Acoustic Swallowing Evaluation N/A
Completed NCT02457052 - Impact of a Transportable Customizable and Scalable Sitting Positioning Device on Swallowing Disorders N/A
Completed NCT02379182 - Effect Of Vitalstim In Patients With Chronic Post-stroke Oropharyngeal Dysphagia N/A
Completed NCT02825927 - Swallowing Function, Oral Health, and Food Intake in Old Age N/A
Active, not recruiting NCT01559649 - Stroke Swallowing Screening Tool Validation N/A
Completed NCT00439439 - ACHAT-STUDY, Alternative Treatment of Chronic Globus Sensations N/A
Completed NCT00141752 - Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke Patients N/A
Completed NCT04369092 - Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia N/A
Terminated NCT02576470 - Motor Learning in Dysphagia Rehabilitation N/A
Completed NCT02003287 - Comparing FEES to VFSS in Diagnosing Laryngeal Penetration and Aspiration in Infants in the NICU N/A
Completed NCT01006330 - Dysphagia in Elderly Medical Patients Phase 4